TransMedics Group, Inc. TMDX Value of common stock issued to settle convertible senior notes

Value of common stock issued to settle convertible senior notes at other companies

Ondas, Inc. ONDS

$439.58K-96.4%

TransMedics Group, Inc.TMDX

$1K—

Applied DigitalAPLD

$0—

Opendoor Technologies IncOPEN

$296M—

Oscar HealthOSCR

$70.83M—

AST SpaceMobileASTS

$0-100%

Other financials

Income statement

See full

Revenue$173.9M+21.2%

Gross profit$101.2M+14.7%

Operating income$13.3M-51.5%

Net income$7.3M-71.5%

EPS (diluted)$0.20-71.4%

Balance sheet

See full

Cash & equivalents$461.7M+48.9%

Total debt$409.9M+505%

Total equity$494.0M+85.5%

Total assets$1.4B+71.3%

Cash flow

See full

Operating cash flow$24.5M+959%

CapEx$36.7M+35.6%

Free cash flow-$12.1M+59.4%

Valuation

See full

Market cap$2.55B+50.6%

Enterprise value$2.5B+66.0%

P/E14.8×-19.8×

P/S4×+0.5×

Profitability

See full

Gross margin59.1%-0.4pp

Operating margin14.9%+4.1pp

Net margin27%+17.0pp

FCF margin23.8%—

Returns & leverage

See full

Return on equity45.2%+22.2pp

Debt / equity0.8×+0.6×

Current ratio6.7×-2.4×

Where this comes from

Reported directly by TransMedics Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DebtConversionConvertedInstrumentAmount1.

The official record: TransMedics Group, Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about TransMedics Group, Inc.'s value of common stock issued to settle convertible senior notes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TransMedics Group, Inc.'s value of common stock issued to settle convertible senior notes?: TransMedics Group, Inc. (TMDX) reported value of common stock issued to settle convertible senior notes of $1K in Q4 2024.
What does value of common stock issued to settle convertible senior notes mean?: Reflects the non-cash value of debt obligations that have been settled through the issuance of common stock. This metric indicates the extent to which the company is deleveraging its balance sheet by converting debt into equity. It is a critical factor for investors to monitor regarding potential shareholder dilution and changes in capital structure.